An agreement is signed between Da Nang Oncology Hospital and AstraZeneca Vietnam to improve treatment capacity and the quality of medical care for lung cancer patients in central Vietnam. (Photo: VNA) Under the agreement, the two sides will cooperate in conductingclinical studies of cancer, developing and implementing programmes in trainingfor medical workers and patients’ support delivery; and promoting internationalcooperation in oncology.
Director of the Da Nang Oncology Hospital Tran Tu Quy saidthe deal will help comprehensively enhance capacity in cancer screening andtreatment and benefit patients in not only Da Nang but also surrounding areas.
On this occasion, the two sides partnered in the programme “VietnamHealthy Lung” between 2021 – 2023, aimed at raising the quality of respiratorydisease management in Vietnam. The programme has entered the second phase withexpansion into the field of lung cancer.
It is estimated that over 4.2 percent of Vietnam’s populationsuffers from Chronic Obstructive Pulmonary Disease. It is worrying that most ofthem are not currently diagnosed due to a lack of medical facilities, poorawareness of patients and limitations in the professional skills of publichealth, according to the health ministry.
Vietnam each year reported about 23,667 new lung cancercases and 20,170 deaths. Most people with cancer in Vietnam visit hospitals formedical examination and treatment in a late stage, making treatment difficultand creating a huge financial burden on patients./.
VNA
